Similar articles

• Variable phenotypic expression of an X-linked recessive lymphoproliferative syndrome.

  Purtilo DT, DeFlorio D Jr, Hutt LM, Bhawan J, Yang JP, Otto R, Edwards W. Purtilo DT, et al. N Engl J Med. 1977 Nov 17;297(20):1077-80. doi: 10.1056/NEJM197711172972001. N Engl J Med. 1977. PMID: 198660
• Opportunistic non-Hodgkin's lymphoma in X-linked recessive immunodeficiency and lymphoproliferative syndromes.

  Purtilo DT. Purtilo DT. Semin Oncol. 1977 Sep;4(3):335-43. Semin Oncol. 1977. PMID: 21454 No abstract available.
• Epstein-Barr virus as an etiological agent in the pathogenesis of lymphoproliferative and aproliferative diseases in immune deficient patients.

  Purtilo DT, Tatsumi E, Manolov G, Manolova Y, Harada S, Lipscomb H, Krueger G. Purtilo DT, et al. Int Rev Exp Pathol. 1985;27:113-83. Int Rev Exp Pathol. 1985. PMID: 3017882 Review. No abstract available.
• Limited immunodeficiency.

  [No authors listed] [No authors listed] Lancet. 1978 Jan 21;1(8056):132-3. Lancet. 1978. PMID: 87559 No abstract available.
• Epstein-Barr virus and human disease: immune responses determine the clinical and pathologic expression.

  Purtilo DT, Sakamoto K. Purtilo DT, et al. Hum Pathol. 1981 Aug;12(8):677-9. doi: 10.1016/s0046-8177(81)80162-1. Hum Pathol. 1981. PMID: 6269987 Review. No abstract available.